**Core Concept**
HMB45 is a monoclonal antibody that targets an antigen present in melanocytic lesions. It is used in immunohistochemistry to identify melanocytic tumors, particularly those of neural crest origin.

**Why the Correct Answer is Right**
HMB45 reacts with an antigen present in the melanosomal proteins of melanocytes and neoplastic cells derived from melanocytes. This allows for the identification of melanocytic lesions such as melanomas, melanocytomas, and neurofibromas. The HMB45 antibody is particularly useful in distinguishing melanocytic lesions from other types of tumors that may mimic them.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because HMB45 is not typically used as a marker for epithelial tumors, such as carcinomas. While melanocytic tumors can arise from epithelial-mesenchymal transition, HMB45 is not a reliable marker for this process.
**Option B:** Incorrect because HMB45 is not primarily used as a marker for lymphoid tumors, such as lymphomas. While some melanocytic tumors can contain lymphoid components, HMB45 is not a specific marker for lymphoid cells.
**Option C:** Incorrect because HMB45 is not typically used as a marker for smooth muscle tumors, such as leiomyomas. While some melanocytic tumors can mimic smooth muscle tumors, HMB45 is not a reliable marker for smooth muscle cells.

**Clinical Pearl / High-Yield Fact**
When interpreting immunohistochemical stains, it's essential to consider the specific antibody used, the type of tumor being evaluated, and the clinical context in which the biopsy was performed. HMB45 is a useful marker for identifying melanocytic tumors, but it should be used in conjunction with other diagnostic tools to ensure accurate diagnosis.

**Correct Answer: C. Melanocytic tumors**